U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C22H23ClN2O8.H2O4S
Molecular Weight 576.958
Optical Activity UNSPECIFIED
Defined Stereocenters 5 / 5
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CHLORTETRACYCLINE BISULFATE

SMILES

OS(O)(=O)=O.[H][C@@]12C[C@@]3([H])C(C(=O)C4=C(C(Cl)=CC=C4O)[C@@]3(C)O)=C(O)[C@]1(O)C(=O)C(C(N)=O)=C(O)[C@H]2N(C)C

InChI

InChIKey=GQUMQTDURIYYIA-MRFRVZCGSA-N
InChI=1S/C22H23ClN2O8.H2O4S/c1-21(32)7-6-8-15(25(2)3)17(28)13(20(24)31)19(30)22(8,33)18(29)11(7)16(27)12-10(26)5-4-9(23)14(12)21;1-5(2,3)4/h4-5,7-8,15,26,28-29,32-33H,6H2,1-3H3,(H2,24,31);(H2,1,2,3,4)/t7-,8-,15-,21-,22-;/m0./s1

HIDE SMILES / InChI

Molecular Formula C22H23ClN2O8
Molecular Weight 478.88
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 5 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Molecular Formula H2O4S
Molecular Weight 98.078
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/17638695 | https://www.ncbi.nlm.nih.gov/pubmed/6404649

Chlortetracycline (trade name Aureomycin, Lederle) is a tetracycline antibiotic, the first tetracycline to be identified. It was discovered in 1945 by Benjamin Minge Duggar working at Lederle Laboratories under the supervision of Yellapragada Subbarow. Duggar identified the antibiotic as the product of an actinomycete he cultured from a soil sample collected from Sanborn Field at the University of Missouri. The organism was named Streptomyces aureofaciens and the isolated drug, Aureomycin, because of their golden color. Chlortetracycline inhibits cell growth by inhibiting translation. It binds to the 16S part of the 30S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome. In veterinary medicine, chlortetracycline is commonly used to treat conjunctivitis in cats.

Approval Year

Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
1560.8 ng/mL
10 mg/kg single, oral
dose: 10 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLORTETRACYCLINE plasma
Gallus gallus domesticus
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
13415.51 ng × h/mL
10 mg/kg single, oral
dose: 10 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLORTETRACYCLINE plasma
Gallus gallus domesticus
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
30.59 h
10 mg/kg single, oral
dose: 10 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLORTETRACYCLINE plasma
Gallus gallus domesticus
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
Funbound

Funbound

ValueDoseCo-administeredAnalytePopulation
50%
10 mg/kg single, oral
dose: 10 mg/kg
route of administration: Oral
experiment type: SINGLE
co-administered:
CHLORTETRACYCLINE plasma
Gallus gallus domesticus
population: HEALTHY
age: ADULT
sex: FEMALE / MALE
food status: FASTED
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Efficacy of chlortetracycline treatment on vulvar non-neoplastic epithelial disorders.
2015
Evaluation of pilot-scale microencapsulation of probiotics and product effect on broilers.
2015 Oct
Patents

Sample Use Guides

In Vivo Use Guide
Cattle: 0.1-10 mg per lb body wt per day; Swine: 10 mg per lb body wt per day; Turkeys: 25 mg per lb body wt per day;
Route of Administration: Oral
Chlortetracycline activity was determined against 37 Mycoplasma putrefaciens isolates. Chlortetracycline was tested at concentrations ranged from 4 to 0.03 mg/ml/ The MIC was defined as the lowest concentration in which there was no bacterial growth, as evidenced by a lack of pH color change at the time the drug-free growth control showed a color change. This change of color was evident after 24 h of incubation.
Substance Class Chemical
Created
by admin
on Fri Dec 15 14:57:31 GMT 2023
Edited
by admin
on Fri Dec 15 14:57:31 GMT 2023
Record UNII
1D06KZ672I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CHLORTETRACYCLINE BISULFATE
GREEN BOOK   MART.   USP  
Common Name English
CHLORTETRACYCLINE BISULFATE [USP MONOGRAPH]
Common Name English
CHLORTETRACYCLINE BISULFATE [GREEN BOOK]
Common Name English
CHLORTETRACYCLINE BISULFATE [MART.]
Common Name English
7-CHLORO-4-(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,6,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-2-NAPHTHACENECARBOXAMIDE BISULFATE
Common Name English
2-NAPHTHACENECARBOXAMIDE, 7-CHLORO-4-(DIMETHYLAMINO)-1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,6,10,12,12A-PENTAHYDROXY-6-METHYL-1,11-DIOXO-, (4S,4AS,5AS,6S,12AS)-, SULFATE (1:1)
Common Name English
CHLORTETRACYCLINE BISULPHATE
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1595
Created by admin on Fri Dec 15 14:57:31 GMT 2023 , Edited by admin on Fri Dec 15 14:57:31 GMT 2023
Code System Code Type Description
SMS_ID
300000023851
Created by admin on Fri Dec 15 14:57:31 GMT 2023 , Edited by admin on Fri Dec 15 14:57:31 GMT 2023
PRIMARY
NCI_THESAURUS
C76989
Created by admin on Fri Dec 15 14:57:31 GMT 2023 , Edited by admin on Fri Dec 15 14:57:31 GMT 2023
PRIMARY
PUBCHEM
54715349
Created by admin on Fri Dec 15 14:57:31 GMT 2023 , Edited by admin on Fri Dec 15 14:57:31 GMT 2023
PRIMARY
ChEMBL
CHEMBL404520
Created by admin on Fri Dec 15 14:57:31 GMT 2023 , Edited by admin on Fri Dec 15 14:57:31 GMT 2023
PRIMARY
FDA UNII
1D06KZ672I
Created by admin on Fri Dec 15 14:57:31 GMT 2023 , Edited by admin on Fri Dec 15 14:57:31 GMT 2023
PRIMARY
DRUG BANK
DBSALT001619
Created by admin on Fri Dec 15 14:57:31 GMT 2023 , Edited by admin on Fri Dec 15 14:57:31 GMT 2023
PRIMARY
CAS
27823-62-7
Created by admin on Fri Dec 15 14:57:31 GMT 2023 , Edited by admin on Fri Dec 15 14:57:31 GMT 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY